Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosamprenavir Expanded Access for HIV
NCT00240552Phase 4Completed
- Sponsor
- ViiV Healthcare
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fosamprenavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Primary endpoint: Long Term Safety and Tolerability. Started Jul 2003; status: completed.
02
Drugs
fosamprenavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00240552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240552.